CHELSEA THERAPEUTICS INT'L LTD
CHTP
CHTP was delisted on the 23rd of June, 2014.
6 hedge funds and large institutions have $4.84M invested in CHELSEA THERAPEUTICS INT'L LTD in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 81 closing their positions.
379% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $2.87M
93% less funds holding
Funds holding: 85 → 6 (-79)
98% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 81
98% less capital invested
Capital invested by funds: $204M → $4.84M (-$199M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$16.4M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$4.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$37.3M |
| 2 |
State Street
Boston,
Massachusetts
|
-$23M |
| 3 |
Millennium Management
New York
|
-$16.5M |
| 4 |
GH
Green Holdings
Hamilton,
Bermuda
|
-$15.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.1M |
CHTP Hedge Fund Activity: Q2 2014 in Review
6 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q2 2014, worth a combined $4.84M — down 98% from $204M a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of CHTP and 2 opened new positions — a net loss of 79 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was Whitebox Advisors, opening a new position worth an estimated $16.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $37.3M sold.
- 6 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q2 2014, down from 85 in Q1 2014.
- Funds reported $4.84M of CHELSEA THERAPEUTICS INT'L LTD stock for Q2 2014, down 98% quarter-over-quarter.
- 2 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q2 2014 and 81 closed out, a net change of -79 holders.
- The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q2 2014 was Whitebox Advisors, an estimated $16.4M added.
- The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q2 2014 was Baker Bros. Advisors, an estimated $37.3M sold.
Based on aggregated 13F filings for Q2 2014.